Daniel N. Swisher, Jr
2020 - Jazz Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $636,000 |
|---|---|
| Option Awards | $1,295,588 |
| Salary | $713,654 |
| Stock Awards | $1,809,598 |
| Other | $16,247 |
| Total | $4,471,087 |
Swisher received $1.8M in stock awards, accounting for 40% of the total pay in 2020.
Swisher also received $636K in non-equity incentive plan, $1.3M in option awards, $713.7K in salary and $16.2K in other compensation.
Rankings
In 2020, Daniel N. Swisher, Jr's compensation ranked 2,519th out of 13,090 executives tracked by ExecPay. In other words, Swisher earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,519 out of 13,090 | 81st |
Division Manufacturing | 964 out of 5,621 | 83rd |
Major group Chemicals And Allied Products | 347 out of 2,254 | 85th |
Industry group Drugs | 298 out of 1,954 | 85th |
Industry Pharmaceutical Preparations | 216 out of 1,459 | 85th |
Pay ratio
| Daniel N. Swisher, Jr's Pay | $4,471,087 |
|---|---|
| Median Employee's Pay | $234,935 |
| Pay Ratio | 19to 1 |
In 2020, the annual total compensation of Daniel N. Swisher, Jr was $4,471,087.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.
The ratio of Daniel N. Swisher, Jr's pay to the pay of median employee was therefore 19 to one.
Swisher's colleagues
We found five more compensation records of executives who worked with Daniel N. Swisher, Jr at Jazz Pharmaceuticals in 2020.
2020
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2020
Kim Sablich
Jazz Pharmaceuticals
Executive Vice President and General Manager, North America
2020
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
2020
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
2020
Robert MSCE
Jazz Pharmaceuticals
Executive Vice President, Global Head of Research and Development
News
June 10, 2022
June 11, 2021
June 12, 2020
June 14, 2019